Kerala government decides to treat under 18 haemophilia patients with Emicizumab

Health

By South First Desk

Jul 26, 2024

The Kerala government said on Friday, 26 July, that it has decided to use the drug Emicizumab to treat all children below the age of 18 having the disorder. 

Health

Around 300 children are expected to benefit from this.

Health

Haemophilia — also known as the royal disease — is a usually inherited bleeding disorder that prevents the blood from clotting properly.

Health

Emicizumab is a medication used to prevent bleeding episodes in people with haemophilia.

Health

It’s a bio-specific antibody that helps blood to clot normally, reducing the risk of bleeding complications.

Health

Kerala has around 2000 haemophilia patients registered under the Ashadhara programme.

Health

Haemophilia A occurs due to low amounts of clotting factor VIII and haemophilia B occurs due to low levels of clotting factor IX .

Health